Technology modernization and the alignment of investments with organizational goals, along with picking the right vendor to partner with, are top of mind for payer executives in 2024, according to a Jan. 30 survey published by digital solutions firm HealthEdge.
Payer
It has been a busy few weeks for Medicare Advantage policy. CMS proposed a slight cut in benchmark rates, and payer executives were split on the impact of rising costs in the business.
Medicaid redeterminations began in April 2023, and all major payers have released their 2023 earnings, revealing which recorded the largest enrollment losses in the Medicaid market.
The Cigna Group is buying back $3.2 billion in common stock through accelerated repurchase agreements with Deutsche Bank and Bank of America, the company announced Feb. 15.
Most private investments in the Medicare Advantage space go to companies specializing in marketing and selling MA plans, according to a Feb. 13 report from the Private Equity Stakeholder Project.
Advertisement
It's no secret that climate change is already affecting insurance markets in places like Florida — but the health insurance industry could be the next to face rising coverage costs as a result of a warming planet, The Wall Street…
Two proposed payer deals have been called off in the face of scrutiny from state officials.
CVS' Aetna will begin offering in-home care services to its Medicare Advantage members with chronic kidney disease.
From New Jersey signing the nation's most comprehensive reform bill into law, to Inova outlining challenges to the CMS administrator, here are five updates on prior authorization that Becker's has reported since Jan. 26:
Montgomery, Ala.-based Baptist Health is suing Humana, alleging the insurer's Medicare Advantage plan underpaid the hospital for drugs purchased through the 340B program.